{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:00:57Z","timestamp":1790874057783,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.schres.2022.10.019","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T18:17:26Z","timestamp":1667931446000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Factors and their weight in reducing life expectancy in schizophrenia"],"prefix":"10.1016","volume":"250","author":[{"given":"Christoph U.","family":"Correll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Hoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Meht\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Wooller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Pungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.schres.2022.10.019_bb0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpsyc.60.6.565","article-title":"Sex differences in the risk of schizophrenia: evidence from meta-analysis","volume":"60","author":"Aleman","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.10.019_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eurpsy.2017.05.022","article-title":"Mortality and the relationship of somatic comorbidities to mortality in schizophreniaA nationwide matched-cohort study","volume":"45","author":"Bitter","year":"2017","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2022.10.019_bb0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess mortality of schizophrenia","volume":"177","author":"Brown","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.10.019_bb0020","series-title":"Duty to Care: Physical Illness in People With Mental Illness","author":"Coghlan","year":"2001"},{"issue":"2","key":"10.1016\/j.schres.2022.10.019_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2022.10.019_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2022.10.019_bb0035","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","article-title":"Comorbidities and mortality in persons with schizophrenia: a swedish national cohort study","volume":"170","author":"Crump","year":"2013","journal-title":"Am. J. Psychiatr."},{"issue":"8","key":"10.1016\/j.schres.2022.10.019_bb0040","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","article-title":"The lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness","volume":"6","author":"Firth","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2022.10.019_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapsychiatry.2015.2923","article-title":"Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis","volume":"73","author":"Galling","year":"2016","journal-title":"JAMA Psychiatry."},{"issue":"6","key":"10.1016\/j.schres.2022.10.019_bb0050","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.schres.2022.10.019_bb0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2022.10.019_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.psym.2013.06.001","article-title":"Increased risk of chronic liver disease in patients with schizophrenia: a population-based cohort study","volume":"55","author":"Hsu","year":"2014","journal-title":"Psychosomatics"},{"issue":"7","key":"10.1016\/j.schres.2022.10.019_bb0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archinte.159.7.733","article-title":"Cigarette smoking and mortality risk: twenty-five\u2013year follow-up of the seven countries study","volume":"159","author":"Jacobs","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.schres.2022.10.019_bb0070","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.schres.2022.10.019_bb0075","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/wps.20060","article-title":"Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies","volume":"12","author":"Kane","year":"2013","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2022.10.019_bb0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/schbul\/sbp152","article-title":"Cigarette smoking and mortality risk in people with schizophrenia","volume":"37","author":"Kelly","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychires.2010.04.027","article-title":"Heart disease treatment and mortality in schizophrenia and bipolar disorder\u2013changes in the danish population between 1994 and 2006","volume":"45","author":"Laursen","year":"2011","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.schres.2022.10.019_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067133","article-title":"Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries","volume":"8","author":"Laursen","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.schres.2022.10.019_bb0095","series-title":"Mental Health and Mental Disorders in the Finnish Adult Population","author":"Lehtinen","year":"1991"},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0100","first-page":"47","article-title":"Antipsychotic drugs and liver injury","volume":"30","author":"Lv","year":"2018","journal-title":"Shanghai Arch. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-2-13","article-title":"A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology","volume":"2","author":"McGrath","year":"2004","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol. Rev."},{"issue":"3","key":"10.1016\/j.schres.2022.10.019_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.psc.2007.04.007","article-title":"Epidemiology of schizophrenia: review of findings and myths","volume":"30","author":"Messias","year":"2007","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.schres.2022.10.019_bb0120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.yco.0000228767.71473.9e","article-title":"Physical health and schizophrenia","volume":"19","author":"Mitchell","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.genhosppsych.2014.11.006","article-title":"Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis","volume":"37","author":"Mitchell","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2022.10.019_bb0130","first-page":"447","article-title":"Global and regional cause-of-death patterns in 1990","volume":"72","author":"Murray","year":"1994","journal-title":"Bull. World Health Organ."},{"issue":"1\u20133","key":"10.1016\/j.schres.2022.10.019_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2013.02.025","article-title":"Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades\u2013a danish nationwide study from 1980 to 2010","volume":"146","author":"Nielsen","year":"2013","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055176","article-title":"Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in DenmarkFinland and Sweden","volume":"8","author":"Nordentoft","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.schres.2022.10.019_bb0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.schres.2021.01.006","article-title":"Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: a korean national cohort study","volume":"228","author":"Oh","year":"2021","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2022.10.019_bb0150","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2022.10.019_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eurpsy.2016.02.004","article-title":"Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders","volume":"35","author":"P\u00e9rez-Pi\u00f1ar","year":"2016","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2022.10.019_bb0160","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/schbul\/sbu138","article-title":"Mortality in schizophrenia and other psychoses: a 10-year follow-up of the \u04d4SOP first-episode cohort","volume":"41","author":"Reininghaus","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.schres.2022.10.019_bb0165","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2022.10.019_bb0170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.schres.2011.04.011","article-title":"The impact of substance use disorders on the course of schizophrenia\u2014a 15-year follow-up study: dual diagnosis over 15 years","volume":"130","author":"Schmidt","year":"2011","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2022.10.019_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jamapsychiatry.2015.2688","article-title":"Association of Mental Disorders with Subsequent Chronic Physical Conditions: world mental health surveys from 17 countries","volume":"73","author":"Scott","year":"2016","journal-title":"JAMA Psychiatry."},{"issue":"6","key":"10.1016\/j.schres.2022.10.019_bb0180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000502293","article-title":"Lifestyle interventions for weight Management in People with serious mental illness: a systematic review with meta-analysis, trial sequential analysis, and meta-regression analysis exploring the mediators and moderators of treatment effects","volume":"88","author":"Speyer","year":"2019","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.schres.2022.10.019_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2021.07.009","article-title":"Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: a prospective total-cohort study","volume":"235","author":"Str\u00f8mme","year":"2021","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12916-016-0734-z","article-title":"Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries","volume":"14","author":"Stubbs","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.schres.2022.10.019_bb0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eurpsy.2018.07.004","volume":"54","author":"Stubbs","year":"2018","journal-title":"Eur Psychiatry."},{"key":"10.1016\/j.schres.2022.10.019_bb0200","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archpsyc.56.8.733","article-title":"Decline in the incidence of schizophrenia in finnish cohorts born from 1954 to 1965","volume":"56","author":"Suvisaari","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2022.10.019_bb0205","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/schbul\/sbx176","article-title":"Comparative effectiveness of antipsychotic drugs for rehospitalization in schizophrenia\u2014a nationwide study with 20-year follow-up","volume":"44","author":"Taipale","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.10.019_bb0210","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.schres.2017.12.010","article-title":"Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia","volume":"197","author":"Taipale","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2022.10.019_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2021.08.015","article-title":"A nationwide study of the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia in Taiwan","volume":"237","author":"Tang","year":"2021","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12911-015-0140-z","article-title":"From prescription drug purchases to drug use periods\u2013a second generation method (PRE2DUP)","volume":"15","author":"Tanskanen","year":"2015","journal-title":"BMC Med. Inform. Decis. Mak."},{"issue":"6","key":"10.1016\/j.schres.2022.10.019_bb0230","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/acps.12913","article-title":"Mortality in schizophrenia: 30-year nationwide follow-up study","volume":"138","author":"Tanskanen","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"issue":"9690","key":"10.1016\/j.schres.2022.10.019_bb0235","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.schres.2022.10.019_bb0240","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","article-title":"Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study","volume":"173","author":"Tiihonen","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006777","article-title":"Is schizophrenia associated with an increased risk of chronic kidney disease?A nationwide matched-cohort study","volume":"5","author":"Tzeng","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.schres.2022.10.019_bb0250","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/wps.20252","article-title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"14","author":"Vancampfort","year":"2015","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2022.10.019_bb0255","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2022.10.019_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/wps.20614","article-title":"The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials","volume":"18","author":"Vancampfort","year":"2019","journal-title":"World Psychiatry"},{"issue":"13","key":"10.1016\/j.schres.2022.10.019_bb0265","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1017\/S0033291717000873","article-title":"Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis","volume":"47","author":"Vermeulen","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.10.019_bb0270","series-title":"The Paradox of Premature Mortality in Schizophrenia: New Research Questions","author":"Wildgust","year":"2010"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422004030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422004030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:48:56Z","timestamp":1760298536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422004030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":54,"alternative-id":["S0920996422004030"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.10.019","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors and their weight in reducing life expectancy in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}